SLC17A6 and Cognitive impairment: Kashani et al. observed that SLC17A6 downregulation was correlated with the degree of cognitive impairment in Brodmann area 9 in patients with Alzheimer's disease (60); the lower the decline in SLC17A6 expression, the greater the degree of cognitive impairment.